The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis

Carla Olivares, Carla Noemí Olivares, Analía Gabriela Ricci, Analía Ricci, Mariela Bilotas, Rosa Inés Barañao, Gabriela Meresman
Fertility and sterility · 2011 · vol. 96(2) , pp. 428–433 · doi:10.1016/j.fertnstert.2011.05.063 · W2111680823
article OA: bronze CC0 ⤵ 57 in-corpus citations
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper investigated the inhibitory effects of celecoxib and rosiglitazone on experimental endometriosis, observing their impact on the condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Cyclooxygenase 2 Inhibitors Endometriosis Pyrazoles Sulfonamides Thiazolidinediones Analysis of Variance Animals Antigens, CD34 Antigens, CD34 Apoptosis Apoptosis Celecoxib Cell Proliferation Cell Proliferation Cyclooxygenase 2 Inhibitors Disease Models, Animal Drug Therapy, Combination Endometriosis Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (56)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:16:42.478857+00:00
License: CC0 · commercial use OK